Full-Spectrum Hemp and Herpes: What Science Suggests, What Consumers Need to Know, and How to Choose Quality Products

Hemp has increasingly attracted attention not only for its wellness and industrial applications but also for its broad-spectrum antimicrobial potential. Preclinical studies have highlighted that hemp-derived cannabinoids, terpenes, and flavonoids can inhibit the growth of drug-resistant bacteria, such as Methicillin-Resistant Staphylococcus aureus (MRSA), various fungi, and certain viruses, including herpes simplex virus and SARS-CoV-2. Compounds including CBD, CBDA, CBG, and CBGA, together with terpenes like beta-caryophyllene and limonene, have been observed to act synergistically, forming a complex chemical matrix that may limit the growth and spread of pathogenic microorganisms while supporting cellular health, immune function, and microbial balance. In this article, we would look at the role of full-spectrum hemp as possible antiviral agents.

What Is Full-Spectrum Hemp Extract?

Full-spectrum hemp extract represents the complete biochemical profile of the hemp plant, preserving not only the major cannabinoids but also minor cannabinoids, terpenes, flavonoids, and over 540 naturally occurring phytochemicals. This broad chemical complexity allows the plant’s compounds to interact in synergy, a phenomenon known as the entourage effect, which amplifies their combined bioactive properties. Unlike CBD isolates, which contain only a single cannabinoid, or broad-spectrum extracts, which remove certain compounds, full-spectrum hemp maintains the plant’s natural ratios and chemical integrity, providing a more authentic and functionally rich product.

The bioactive compounds in full-spectrum hemp are diverse, including a blend of cannabinoids (neutral and acidic), terpenes, flavonoids, esters, phenols and more. Cannabinoids such as CBD, CBDA, CBG, and CBGA interact with the endocannabinoid system and may influence microbial balance, inflammation, and immune function. Terpenes, including beta-caryophyllene, limonene, and linalool, contribute aromatic complexity and can enhance the activity of cannabinoids. Flavonoids, such as cannflavins, luteolin, and quercetin, provide antioxidant and anti-inflammatory potential, while other minor phytochemicals further enrich the extract’s chemical landscape.

Extraction methods play a critical role in maintaining this full chemical profile. Techniques such as supercritical CO₂, cold-press, or ethanol extraction are used to preserve delicate compounds while minimizing degradation. By retaining the entire natural composition of the hemp plant, full-spectrum extracts offer a multifunctional approach to wellness, supporting potential antimicrobial activity, immune health, and cellular balance.

What you should know about the Herpes Simplex Virus (HSV-1 and HSV-2)

The Herpes Simplex Virus (HSV) is a DNA virus belonging to the Herpesviridae family, a large group of viruses known for establishing lifelong latent infections. HSV primarily affects epithelial tissues, such as the skin and mucous membranes, and establishes latency in sensory nerve cells, which allows it to reactivate periodically. This family also includes medically significant viruses such as Varicella-Zoster Virus (causing chickenpox and shingles), Epstein-Barr Virus (linked to mononucleosis and certain cancers), and Cytomegalovirus (which can cause severe disease in immunocompromised individuals). Like its relatives, HSV exhibits a characteristic ability to remain dormant in nerve cells and reactivate under certain conditions.

HSV has two primary strains: HSV-1, most commonly linked to oral infections such as cold sores, and HSV-2, typically responsible for genital herpes. Both strains establish lifelong latency in sensory neurons, and periodic reactivation can lead to symptomatic outbreaks. Triggers for reactivation include stress, hormonal changes, immune suppression, physical trauma, and other illnesses.

HSV infections can manifest in multiple ways:

Oral herpes (HSV-1): Cold sores or fever blisters around the mouth, lips, or face.
Genital herpes (HSV-2): Painful lesions in the genital and anal regions.
Ocular herpes: Infection of the eyes, potentially affecting vision.
Herpetic whitlow: Appears on fingers or hands due to direct contact with infected areas.
Neonatal herpes: Rare but serious, occurring when an infant is exposed during childbirth.

Globally, HSV is a major public health concern. The World Health Organization estimates that approximately 3.8 billion people under 50 are infected with HSV-1, and over 520 million live with HSV-2. Beyond physical discomfort, HSV can impact mental health, social interactions, and overall quality of life.

How is Herpes virus spread?

Outbreaks of herpes virus occur when latent viruses in nerve cells become active, travel along nerve pathways, and infect epithelial tissues. Viral shedding can occur even without visible symptoms, making HSV highly contagious. While initial infections may be more severe recurrent episodes are often shorter and less intense, though frequency varies among individuals.

What Does Research Says About Hemp Compounds and Viral Activity?

The antiviral activity of hemp-based compounds such as cannabinoids, terpenes, and flavonoids was reported on both enveloped and non-enveloped viruses including herpes simplex virus (HSV), hepatitis C virus (HCV), HIV, influenza virus, SARS-CoV-2 (COVID-19), Epstein-Barr virus (EBV), Kaposi’s sarcoma-associated herpesvirus (KSHV or HHV-8), and Zika virus in our previous article.

These compounds exhibit what researchers describe as a broad-spectrum antiviral potential, which means they may influence multiple stages of the viral life cycle across a variety of pathogens. While most findings remain in the in vitro or preclinical stage, the mechanisms observed provide meaningful insight into how hemp-based compounds could support the body’s natural defenses. Their antiviral activity is believed to involve several complementary processes, including:

Preventing viral entry into host cells, which limits the ability of viruses to bind, fuse, and establish infection in epithelial or immune cells.
Interfering with viral replication, particularly by modulating cellular pathways that viruses rely on to copy their genetic material.
Supporting the body’s innate immune response, which enhances the activity of frontline defense systems such as interferons and natural killer cells.
Modulating immune cell behavior, helping maintain balance in inflammatory signaling and reducing excessive immune activation that may worsen symptoms.
Reducing inflammatory reactions, which can help minimize tissue irritation, discomfort, and the secondary effects associated with viral outbreaks.

Hemp-derived compounds of Interest as possible antiviral agents

Growing preclinical evidence indicates that several naturally occurring compounds in hemp, including cannabinoids, terpenes, and flavonoids, may influence viral activity through one or more of the mechanisms discussed above. In most cases, these compounds acting singly or in synergy via the entourage effect affect biological pathways that limit the growth and spread of viral particles. Some of the commonly reported hemp-derived compounds of interest as possible antiviral agents are discussed below.

CBDA (Cannabidiolic Acid)

CBDA (cannabidiolic acid) is one of the most promising acidic cannabinoids for antiviral potential. Laboratory research from 2022 demonstrates that CBDA can bind directly to the SARS-CoV-2 spike protein, a key viral structure required for entry into host cells. This interaction helps block the initial attachment of the virus, preventing infection in human epithelial cells. In vitro studies have shown that CBDA significantly reduced viral titers of multiple SARS-CoV-2 variants by over 90 percent at micromolar concentrations. Its antiviral activity is largely attributed to its carboxylic acid group, which is absent in CBD, allowing unique molecular interactions with viral proteins that neutral cannabinoids cannot achieve.

However, CBDA is chemically unstable and prone to decarboxylation into CBD when exposed to heat, light, or prolonged storage. This instability makes it extremely challenging to preserve its bioactive form, which limits its availability in commercial products. Only a few companies have developed methods to extract, stabilize, and maintain CBDA at therapeutically relevant concentrations, often through cold-press extraction or low-heat stabilization techniques. To overcome the instability of CBDa, researchers often synthesize its methyl ester which was also found to have a neutralizing effect against all variants of SARS-CoV-2 tested and with greater affinity than CBDA.

CBDa also influences pathways involved in inflammation and immune response (COX-2, TRPV1, 5-HT1A), which may indirectly support the body during viral stress, but this is supportive, not antiviral.

CBGA (Cannabigerolic Acid)

CBGA, often nicknamed the mother of cannabinoids, is the acidic precursor to CBG and many other cannabinoids. It has demonstrated promising antiviral activity in laboratory studies especially against the original SARS-CoV-2 strain and its early variants (alpha and Beta variants).

Like CBDA, CBGA can bind to viral spike proteins, blocking attachment to host cells, and additionally inhibits the viral main protease (Mpro), an enzyme essential for viral replication. In vitro assays with SARS-CoV-2 and its early variants have shown significant reductions in viral titers at micromolar concentrations.

Similar to CBDA, CBGA is chemically unstable and prone to decarboxylation into CBG under heat or prolonged storage, making it difficult to maintain in its active form. Only specialized extraction and stabilization methods, often involving low-heat or cold-press processes, can preserve CBGA’s bioactivity.

Delta-9 THC (Δ9-THC)

Controlled levels of Δ9-tetrahydrocannabinol (Δ9-THC) have been investigated for antiviral effects beyond its well-known psychoactive properties. Preclinical studies suggest that THC may inhibit viral replication by interacting with viral enzymes, such as the SARS-CoV-2 main protease (Mpro). By targeting Mpro, THC can slow the processing of viral polyproteins, which is essential for viral replication, thereby reducing viral proliferation. Additionally, THC modulates immune responses through cannabinoid and non-cannabinoid receptors, reducing pro-inflammatory cytokines and potentially helping manage inflammation associated with viral infections.

In laboratory models, Δ9-THC has shown antiviral activity against gamma-herpesviruses, including Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV). Studies indicate that THC can inhibit lytic replication by interfering with viral gene promoters required for reactivation from latency, suggesting a potential role in controlling persistent viral infections.

CBD (Cannabidiol)

CBD is one of the most widely studied cannabinoids for its potential antiviral and immune-modulating properties. Laboratory research suggests that CBD may reduce viral replication by influencing multiple molecular pathways, including downregulating viral entry receptors such as ACE2 and TMPRSS2. By interfering with these receptors, CBD can limit the ability of viruses like SARS-CoV-2 to attach to and invade host cells. Additionally, CBD has been shown to stimulate components of the innate immune system, including interferon signaling, which helps the body mount an early defense against viral infections.

Beyond its antiviral effects, CBD exhibits strong anti-inflammatory activity. In vitro and animal studies have demonstrated that CBD can modulate cytokine production, reduce excessive immune responses, and protect cells from inflammation-induced damage. These properties are particularly relevant in viral infections where inflammation contributes to disease severity, such as COVID-19.

CBD has been investigated against several viruses, including SARS-CoV-2, HIV, and Hepatitis C (HCV). Early research suggests that it may help reduce viral load, inhibit viral replication, and mitigate the immune-related symptoms associated with infection.

Although CBD is chemically stable compared to acidic cannabinoids like CBDA, its full therapeutic potential is often realized when combined with other hemp compounds in full-spectrum formulations, allowing synergistic interactions with terpenes, flavonoids, and minor cannabinoids to enhance overall antiviral and immune-supporting effects.

Beta-Caryophyllene (BCP) and Other Terpenes

Terpenes such as beta-caryophyllene (BCP) contribute additional antiviral and anti-inflammatory activity. BCP is a CB2 receptor agonist known to reduce pro-inflammatory cytokines and modulate immune function. Some terpenes have also shown direct antiviral effects in early studies involving SARS-CoV-2 and Herpes Simplex Virus, reinforcing the importance of terpene-rich full-spectrum extracts.

Hemp Flavonoids (Cannflavins A, B, and C)

Hemp flavonoids, particularly cannflavins A, B, and C, contribute significant anti-inflammatory and potential antiviral activity. Laboratory studies suggest these flavonoids can inhibit viral enzymes, reduce inflammatory mediators, and protect cells from oxidative stress. Cannflavins have been explored for their ability to modulate immune responses during viral infection, complementing the effects of cannabinoids and terpenes.

Flavonoids are generally more stable than acidic cannabinoids, but their concentrations in crude hemp extracts are low. Full-spectrum or enriched extracts are therefore preferred to maximize flavonoid content and achieve synergistic antiviral effects alongside cannabinoids and terpenes.

Use Case: Our Experiment With Full-Spectrum Hemp and Wellness Support

Our team at BioSource Botanicals documented two personal cases where individuals experimented with full-spectrum hemp during recurrent herpes outbreaks. THIS IS NOT MEDICAL ADVICE AND IS SHARED PURELY AS A RECORD OF PERSONAL WELLNESS EXPERIENCES. NO CLAIMS ARE BEING MADE ABOUT TREATMENT, CURE, OR PREVENTION.

In the first case, the individual followed a two-week routine. For the first eight days, he used four suppositories per day containing higher levels of THCa, THC, CBGa, and CBDa. This phase focused on observing how acidic cannabinoids felt as part of his wellness routine. For the next six days, he switched to four suppositories per day containing CBDVa, CBDV, CBDa, and CBD, while also taking oral full-spectrum CBGa and CBDa extracts. In addition, a THCa and THC full-spectrum oil was applied topically to the penis three times daily. Throughout the period, his impressions were clinically examined, and results are available upon request.

The second case involved an individual who used a full-spectrum extract containing very high percentages of CBDa and CBGa along with naturally occurring terpenes and flavonoids such as cannflavins. He reported a strong personal reaction to this combination during his outbreak. According to his feedback, the experience felt noticeably different from his usual routine. He described his response as significant and worth documenting, though no medical conclusions can be drawn from his impressions. In addition to the extract, he also used a THCa and THC suppository and reported no noticeable psychoactive effect.

The extracts used in these cases were full-spectrum hemp formulations, carefully selected for their naturally occurring cannabinoids, terpenes, and flavonoids such as cannflavins. The first phase included higher levels of acidic cannabinoids like THCa, THC, CBGa, and CBDa, while the second phase introduced a broader spectrum including CBDVa, CBDV, CBDa, and CBD, along with oral CBGa and CBDa extracts. These combinations allowed us to observe a wide variety of cannabinoid profiles and delivery methods, including suppositories, oral extracts, and topical applications. While we cannot claim therapeutic effects, our observations suggest that the synergy of cannabinoids, terpenes, and flavonoids in these full-spectrum extracts created a notably positive personal experience in terms of overall comfort and wellness, with each individual reporting a response that they found remarkable.

How to Choose a High-Quality Full-Spectrum Hemp Product?

Selecting a full-spectrum hemp product requires careful attention to quality, authenticity, and composition. Here are key considerations:

→ Read Certificates of Analysis (COAs)

Reputable manufacturers provide independent laboratory COAs that detail cannabinoid content, terpene profiles, and safety testing for pesticides, heavy metals, and solvents. Reviewing COAs ensures you are getting exactly what the label claims and demonstrates transparency from the brand.

→ Avoid Engineered “Fake Full-Spectrum” Blends

Some products are marketed as full-spectrum but are artificially blended using isolated cannabinoids. These lack the natural synergy of hemp compounds and may not provide the holistic experience full-spectrum extracts are known for. Choosing verified full-spectrum products preserves the integrity of the plant’s natural profile.

→ Check for Terpenes and Minor Cannabinoids

Terpenes and minor cannabinoids like CBGa, CBC, and CBDA contribute to the unique effects of full-spectrum hemp. High-quality products retain these compounds, ensuring a complete representation of the plant’s chemistry and supporting a well-rounded wellness experience.

References:

André, R., Gomes, A. P., Pereira-Leite, C., António Marques-da-Costa, Rodrigues, L. M., Sassano, M., Rijo, P., & Maria. (2024). The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review. Pharmaceuticals, 17(11), 1543–1543. doi.org/10.3390/ph17111543
BioSource Botanicals . (2024, December 18). Cannabis As Antiviral Against Herpes | BioSource Botanicals. BioSource Botanicals. biosourcebotanicals.com/cannabis-as-antiviral-against-herpes/
Cabral, G. A., Rogers, T. J., & Lichtman, A. H. (2015). Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. Journal of Neuroimmune Pharmacology, 10(2), 193–203. doi.org/10.1007/s11481-015-9615-z
Cleveland Clinic. (2022a). Herpes Simplex: Genital, Oral, Symptoms & Treatment. Cleveland Clinic. my.clevelandclinic.org/health/diseases/22855-herpes-simplex
Cleveland Clinic. (2022b, July 13). Epstein-Barr Virus (EBV) – Symptoms, Causes & Treatment. Cleveland Clinic. my.clevelandclinic.org/health/diseases/23469-epstein-barr-virus
Cleveland Clinic. (2024, April 2). What Is Varicella-Zoster Virus? Cleveland Clinic. my.clevelandclinic.org/health/diseases/varicella-zoster-virus
Janecki, M., Graczyk, M., Lewandowska, A. A., & Pawlak, Ł. (2022). Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection. International Journal of Molecular Sciences, 23(8), 4170. doi.org/10.3390/ijms23084170
Jha, N. K., Sharma, C., Hashiesh, H. M., Arunachalam, S., Meeran, M. N., Javed, H., Patil, C. R., Goyal, S. N., & Ojha, S. (2021). β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Frontiers in Pharmacology, 12. doi.org/10.3389/fphar.2021.590201
Mahmud, M. S., Hossain, M. S., Ahmed, A. T. M. F., Islam, M. Z., Sarker, M. E., & Islam, M. R. (2021). Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review. Molecules, 26(23), 7216. doi.org/10.3390/molecules26237216
Martini, S., Gemma, A., Ferrari, M., Cosentino, M., & Marino, F. (2023). Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance. International Journal of Molecular Sciences, 24(4), 3125. doi.org/10.3390/ijms24043125
Mayo clinic. (2022, March 23). Cytomegalovirus (CMV) infection – Symptoms and causes. Mayo Clinic. mayoclinic.org/diseases-conditions/cmv/symptoms-causes/syc-20355358
Medveczky, M. M., Sherwood, T. A., Klein, T. W., Friedman, H., & Medveczky, P. G. (2004). Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro. BMC Medicine, 2, 34. doi.org/10.1186/1741-7015-2-34
National Center for Complementary and Integrative Health. (2019). Cannabis (Marijuana) and Cannabinoids: What You Need to Know. NCCIH. nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
Oregon State research shows hemp compounds prevent coronavirus from entering human cells | Newsroom. (2022, January 11). Newsroom. news.oregonstate.edu/news/oregon-state-research-shows-hemp-compounds-prevent-coronavirus-entering-human-cells
Tamburello, M., Salamone, S., Anceschi, L., Paolo Governa, Brighenti, V., Morellini, A., Rossini, G., Manetti, F., Giorgio Gallinella, Pollastro, F., & Federica Pellati. (2023). Antiviral Activity of Cannabidiolic Acid and Its Methyl Ester against SARS-CoV-2. Journal of Natural Products, 86(7), 1698–1707. doi.org/10.1021/acs.jnatprod.3c00111
Toyang, N., Lowe, HenryI. C., & McLaughlin, W. (2017). Potential of cannabidiol for the treatment of viral hepatitis. Pharmacognosy Research, 9(1), 116. doi.org/10.4103/0974-8490.199780
van Breemen, R. B., Muchiri, R. N., Bates, T. A., Weinstein, J. B., Leier, H. C., Farley, S., & Tafesse, F. G. (2022). Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants. Journal of Natural Products. doi.org/10.1021/acs.jnatprod.1c00946
World Health Organization. (2024, December 11). Herpes simplex virus. Who.int; World Health Organization: WHO. who.int/news-room/fact-sheets/detail/herpes-simplex-virus
Zakaryan, H., Arabyan, E., Oo, A., & Zandi, K. (2017). Flavonoids: promising natural compounds against viral infections. Archives of Virology, 162(9), 2539–2551. doi.org/10.1007/s00705-017-3417-y